EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Battlegrounds of treatment resistance: decoding the tumor microenvironment

Mobina Bayat, Javid Sadri Nahand

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-09 · 398 (9) · 11179-11197

DOI: 10.1007/s00210-025-04055-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 25.03.2025. Verfasst von Mobina Bayat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 220 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) emerges as a formidable actor in the cancer treatment landscape, wielding the power to thwart therapeutic efficacy across various modalities, including chemotherapy, radiotherapy, immunotherapy, targeted therapy, and hormonal therapy. This intricate ecosystem comprising diverse cellular constituents, signaling molecules, and the extracellular matrix fosters a dynamic interplay that profoundly influences tumor behavior and treatment outcomes. This review explores the mechanisms through which the TME drives resistance to standard therapies, emphasizing key factors such as hypoxia, immune evasion, and metabolic reprogramming. Furthermore, we illuminate innovative strategies aimed at reprogramming this hostile environment, including the application of therapeutic vaccines, CAR T cell therapy, and combination immunotherapies designed to enhance anti-tumor responses. By advocating for multidimensional approaches that dismantle the TME's barriers to effective treatment, this review calls for a transformative shift in cancer treatment paradigms. By bridging the gap between the TME's complexities and targeted therapeutic strategies, we pave the way for targeted interventions that promise to enhance clinical outcomes and improve patient prognosis in the relentless battle against cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsDrug Resistance, NeoplasmHumansAnimalsImmunotherapy

Stichwörter der Autor:innen

Targeted therapyTreatment resistanceTumor microenvironmentTumor-immune therapy

Autor:innen und Institutionen

  • Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. javidsadri65@gmail.com.
  • Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. javidsadri65@gmail.com.

Zitieren

APA

Bayat, M., & Nahand, J. S. (2025). Battlegrounds of treatment resistance: decoding the tumor microenvironment. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(9), 11179-11197. https://doi.org/10.1007/s00210-025-04055-5

Vancouver

Bayat M, Nahand JS. Battlegrounds of treatment resistance: decoding the tumor microenvironment. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(9):11179-11197. doi:10.1007/s00210-025-04055-5

BibTeX
@article{Bayat2025,
  author = {Bayat, Mobina and Nahand, Javid Sadri},
  title = {Battlegrounds of treatment resistance: decoding the tumor microenvironment},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {9},
  pages = {11179--11197},
  doi = {10.1007/s00210-025-04055-5}
}
Kostenlos starten →